Canabidol™ CBD cannabis oil (CBD Oli) is derived from EU approved, UK & US legal, industrial hemp (Cannabis Sativa L.) The active ingredient is Cannabidiol as our products are THC free, meaning that they are non psychoactive so will not get you high. CBD Oil (Cannabidiol) is not scheduled and is found in all hemp products which makes it legal in both the UK and US. Manufactured in England to the highest standards Canabidol™ is now sent out from our United Kingdom distribution centre. You can also purchase our range of CBD oil products direct from one of our many stores across the UK.
Actually, no. BUT...there’s a very good reason for that! Because Functional Remedies’ hemp oil, Hemp Tincture and other sustainable hemp products are classified as dietary supplements by the FDA, we can’t make any specific claims as to what diseases and conditions they treat. So, while we are unable to speak to specific diseases and conditions, there are large (and growing) array of sites, online resources, and scientific research from around the world that point to the many beneficial uses of hemp oil. We also encourage you to sign up for our email list and we’ll send you lots of valuable information about hemp as well as updates and news that are cutting edge.
The cost of treatment varies: Depending on the dispensary and the dosage, it can range from around $100 a month to more than $1,000. Despite the cost, which is not covered by insurance, CBD medicines are drawing great interest for children with severe, intractable epilepsy. California and Colorado, which were among the first states to legalize medical marijuana, have become hot spots for such patients. Before other states legalized medicinal CBD use, some families moved to these states so they could have access to the compound.
In order to create a system where oils can be provided to patients when the original prescription is expressed in grams of dried product, each Licensed Producer must provide an ‘Equivalency Factor’. This allows you to see how much oil you can purchase to be in line with your prescription and ensures that you do not go over your prescribed allowance. For example, a 60ml bottle of Blueberry Lamsbread Cannabis Oil, which has an equivalency factor of 12 ml of oil to 1 gram of dried cannabis, will use 5 grams of your possession limit.
A survey led by the McGill University Health Centre in Canada revealed that cannabis use results in an improvement in non-cancer pain, sleep, and the mood patterns. In the same survey, it also revealed that ‘high’ and dry mouth were the most commonly reported side effects. People who suffer from cancer also turn to cannabis-related options, including therapeutic grade CBD oil, when the pain of chemotherapy or the disease itself becomes unbearable.
But Hague has something else he wants to show me. He leads me into a moist propagation room, where a young crop is taking root in near darkness. These babies, tagged with yellow labels, are being grown strictly for medical purposes. They’re all clones, cuttings from a mother plant. Hague is proud of this variety, which contains almost no THC but is rich in CBD and other compounds that have shown at least anecdotal promise in treating such diseases and disorders as multiple sclerosis, psoriasis, post-traumatic stress disorder, dementia, schizophrenia, osteoporosis, and amyotrophic lateral sclerosis (Lou Gehrig’s disease).
Scientific studies have established that synthetic, single-molecule hemp-oils have a very narrow window of efficacy and requires great precision to achieve that efficacy, whereas lower concentration, whole-plant, full-spectrum, phyto-nutrient rich nutritional supplement regimens are already showing efficacy for many. Full-spectrum compounds interact collectively and enhance their therapeutic benefits. Scientists call this the “entourage effect.” Numerous hemp compounds have medicinal attributes, but the therapeutic impact of whole plant hemp is greater than the sum of its parts.
The side effects and risks involved with consuming marijuana-based products aren't clear, either, Bonn-Miller said. It's important to "determine cannabinoids that are useful therapeutically while understanding and using cannabinoids that are associated with less risk," he said. At least with CBD, he said, it doesn't appear to have the potential for addiction. That's different from THC, which has been associated with addiction, he said, and negative side effects, including acute anxiety.
Two cannabis-based pharmaceutical drugs, manufactured in the UK, are licensed for prescription but only for very specific uses. Sativex has been available in the UK since 2010 and uses THC and CBD to treat spasticity in multiple sclerosis. And a new CBD-only drug, Epidiolex, was approved in June in the US to treat rare childhood epilepsies, with a similar decision expected imminently for Europe and the UK.
Cannabis has shown to have positive effects on people suffering from epilepsy and multiple sclerosis. A research conducted in the University College of London, it is also effective in dealing with multiple other neurological conditions like the Dravet syndrome and Parkinson’s disease. It prevents neurodegeneration and cognitive decline, thereby helping those suffering from Alzheimer’s.
Preliminary research indicates that cannabidiol may reduce adverse effects of THC, particularly those causing intoxication and sedation, but only at high doses. Safety studies of cannabidiol showed it is well-tolerated, but may cause tiredness, diarrhea, or changes in appetite as common adverse effects. Epidiolex documentation lists sleepiness, insomnia and poor quality sleep, decreased appetite, diarrhea, and fatigue.
“THC products are more for the psychoactive effect, which may not be for everyone,” the Steamboat Springs, Colorado, resident says. “CBD use is for more health-minded people.” Collins says CBD products “are a big part of my daily routine,” and credits them with boosting his energy levels, speeding his recovery from long trail runs, and improving his sleep.
But now, as more and more people are turning to the drug to treat ailments, the science of cannabis is experiencing a rebirth. We’re finding surprises, and possibly miracles, concealed inside this once forbidden plant. Although marijuana is still classified as a Schedule I drug, Vivek Murthy, the U.S. surgeon general, recently expressed interest in what science will learn about marijuana, noting that preliminary data show that “for certain medical conditions and symptoms” it can be “helpful.”
Zuardi, A. W., Crippa, J. A., Hallak, J. E., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., … & Guimarães, F. S. (2012). A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation [Abstract]. Current Pharmaceutical Design, 18(32), 5,131–5,140. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22716160
Medical Disclaimer: Statements in any video or written content on this site have not been evaluated by the FDA. If you are pregnant, nursing, taking medications, or have a medical condition, consult your physician before using this product. Representations regarding the efficacy and safety of CBD oil have not been evaluated by the Food and Drug Administration. The FDA only evaluates foods and drugs, not supplements like these products. These products are not intended to diagnose, prevent, treat, or cure any disease. The material on this site is provided for informational purposes only and is not medical advice. Always consult your physician before beginning any supplement program.
Copyright © thehealthylifeforever.com